tiprankstipranks
Trending News
More News >
BioLargo Inc (BLGO)
OTHER OTC:BLGO
US Market

BioLargo (BLGO) Earnings Dates, Call Summary & Reports

Compare
63 Followers

Earnings Data

Report Date
May 14, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
0
Last Year’s EPS
0
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 31, 2025
|
% Change Since: -17.86%
|
Next Earnings Date:May 14, 2025
Earnings Call Sentiment|Positive
BioLargo's earnings call presented a positive outlook, with significant revenue growth and advancements across its subsidiaries. However, challenges in specific projects and revenue fluctuations in key products indicate areas needing attention. Overall, the sentiment is optimistic with caution regarding operational hurdles.
Company Guidance
In the BioLargo Annual 2024 Earnings Results call, the company provided several key metrics that underscore its growth and future potential. The company reported a 45% increase in overall sales and revenue, reaching nearly $18 million. Specific subsidiaries also showed significant growth, with Odor-No-More's revenue increasing by 36%, contributing $5.9 million in operating income. The engineering division saw a 183% increase in third-party revenue, although it still operated at a loss of $1.45 million, down from $1.6 million the previous year. Clyra Medical Technologies, a subsidiary focused on medical products, was identified as the majority contributor to the net loss, which decreased to $4.3 million from $4.6 million. Moreover, the company highlighted substantial investments and partnerships, particularly in the battery and PFAS sectors, indicating a multibillion-dollar opportunity in battery technology and significant cost-saving potential in PFAS treatment. BioLargo also maintained a strong balance sheet with $3.5 million in cash and an increase in accounts receivable, reflecting its expanding business. The company aims to continue its upward trajectory with strategic partnerships and product innovations, setting the stage for potential exits and increased shareholder value.
Significant Revenue Growth
BioLargo achieved an overall sales and revenue increase of 45%, reaching nearly $18 million. The growth was driven by various subsidiaries, showcasing an accelerated growth path.
Impressive Subsidiary Performance
Odor-No-More saw a revenue increase of 36%, generating $5.9 million in operating income. The engineering division also experienced revenue growth of 183%.
Positive Balance Sheet Developments
BioLargo reported a strong balance sheet, maintaining $3.5 million in cash, increased accounts receivable due to business development, and reduced overall debt.
Pooph Product Success
The Pooph product line, with eight unique products and 15 SKUs, has been performing exceptionally well in retail, contributing significantly to revenue growth.
Clyra Medical Nearing Market Readiness
Clyra Medical is approaching the launch of its innovative product, with significant investments in manufacturing and a successful inspection confirming scale capability.
---

BioLargo (BLGO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BLGO Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 14, 20252025 (Q1)
- / -
Mar 31, 20252024 (Q4)
0.00 / >-0.01
0
Nov 14, 20242024 (Q3)
0.00 / >-0.01
-0.0180.00% (<+0.01)
Aug 14, 20242024 (Q2)
0.00 / >-0.01
-0.0190.00% (<+0.01)
May 14, 20242024 (Q1)
- / 0.00
-0.001
Apr 02, 20242023 (Q4)
0.00 / >-0.01
-0.0010.00% (0.00)
Nov 20, 20232023 (Q3)
0.00 / -0.01
-0.002-400.00% (>-0.01)
Aug 15, 20232023 (Q2)
0.00 / -0.01
-0.005-100.00% (>-0.01)
May 17, 20232023 (Q1)
- / -
-0.006
Apr 03, 20232022 (Q4)
0.00 / >-0.01
-0.00683.33% (<+0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

BLGO Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 31, 2025$0.28$0.280.00%
Nov 14, 2024$0.20$0.200.00%
Aug 14, 2024$0.24$0.240.00%
May 14, 2024$0.36$0.32-11.11%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does BioLargo Inc (BLGO) report earnings?
BioLargo Inc (BLGO) is schdueled to report earning on May 14, 2025, TBA Not Confirmed.
    What is BioLargo Inc (BLGO) earnings time?
    BioLargo Inc (BLGO) earnings time is at May 14, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BLGO EPS forecast?
          BLGO EPS forecast for the fiscal quarter 2025 (Q1) is 0.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis